Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology.
Hoa S, Laaouad L, Roberts J, Ennis D, Ye C, Al Jumaily K, Pope J, Nevskaya T, Saltman A, Himmel M, Rottapel R, Ly C, Colmegna I, Fifi-Mah A, Maltez N, Tisseverasinghe A, Hudson M, Jamal S.
Hoa S, et al. Among authors: tisseverasinghe a.
Cancer Immunol Immunother. 2021 Aug;70(8):2197-2207. doi: 10.1007/s00262-021-02851-5. Epub 2021 Jan 20.
Cancer Immunol Immunother. 2021.
PMID: 33471137
Free PMC article.
Clinical Trial.